mydecine Archives | Psychedelic Spotlight

News
Culture
Business
- News
- Editorial
- Stock Reports
- Videos
- Interviews
Research
Treatment
Media
- Podcast
- Videos
About
- Work With Us
- Contact Us
Policy
Search
Menu Menu

Home1 / Psychedelic Spotlight News2 / mydecine

Posts

Psychedelic Business News Spotlight - December 24

Psychedelic Business Spotlight – December 24

This week in psychedelic business news: FDA green lights a new psilocybin study; MindMed commences LSD treatment for ADHD; Sage Institute shuffles leadership.

0 Comments

December 24, 2021

https://psychedelicspotlight.com/wp-content/uploads/2021/12/Psychedelic_Business_Spotlight_Mydecine_Tryp_Therapeutics_MindMed_Sage_Institute_Ixtlan_Bioscience_Psychedelic_Spotlight.jpg 962 1920 Travis Reilly http://psychedelicspotlight.com/wp-content/uploads/2021/11/Psych_Sptlgt_Horizontal1-300x38.png Travis Reilly2021-12-24 17:53:262022-06-07 23:17:15Psychedelic Business Spotlight – December 24

Psychedelic Spotlight is your reliable source for the latest stories in the emerging psychedelics industry, covering breakthrough discoveries, investor news and cultural reform.

Terms & Conditions

By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.

Your email(Required)

Scroll to top

Get a roundup of Psychedelic news stories in your inbox

By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.

Which list would you like to subscribe to?(Required)

Psychedelic News

Psychedelic Stock Updates

Email(Required)